Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
about
Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Epigenetic control of phospholipase A2 receptor expression in mammary cancer cellsSelective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.Basal-like breast cancer: molecular profiles, clinical features and survival outcomesEpigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.Tamoxifen Action in ER-Negative Breast Cancer.Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1Zebrafish Discoveries in Cancer Epigenetics.Unique epigenetic gene profiles define human breast cancers with poor prognosis.Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype.The 8th international symposium on the breast: Using next-generation science to understand the normal breast and the development of breast cancer- conference report.The role of BRCA status on prognosis in patients with triple-negative breast cancer.Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression.Antioxydation And Cell Migration Genes Are Identified as Potential Therapeutic Targets in Basal-Like and BRCA1 Mutated Breast Cancer Cell Lines.
P2860
Q30910707-9BCF2DEB-BAD7-4569-B71E-E2710413ACD6Q30978083-E8534998-AAC8-4122-A98D-401A770EF4FDQ35870127-EAA5967E-2E8C-4229-8098-E716ED18426FQ35930608-CDE4F242-2849-489B-92D6-B2E4553C3502Q36213724-7DAB7C67-64AF-45C2-89E6-3D9F09D1671EQ36325873-2F2B456A-D91B-42BB-8990-6B92ED90BFC1Q36503782-46DAFD30-DEF1-48EA-BD11-450013335024Q36544024-DBA1D635-FF42-46AB-95AA-BD5012E9FD7CQ36688302-B0AD8C28-4D09-4411-AB55-62D1B19EB3B3Q37536796-016100D3-98B0-4C71-BD4D-F1610E0D0A79Q37651410-3BA3621C-F56B-497E-B702-F6C58FAFEE87Q37699138-D975D28A-9737-4476-B4B7-8DEFD13573C8Q38694763-2D16E6D2-1767-4BC9-BC25-16C7BCCEA727Q39247899-DD0D1F47-C709-456F-88EA-566DF961FD22Q42700663-EE3EB992-62D6-4BCF-9FB5-E02DD2597D38Q46647592-036219CD-77BB-4C52-A309-FC800AC7D3B1Q47097677-BF983047-91FF-4E09-B126-9B4397E51D83Q47432914-C1B7A439-8E68-428D-A0E3-7ED343F39EE4Q50042972-CA547EC5-AC33-43E6-8619-FF67AEDB2B76
P2860
Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dysregulation of the epigenome ...... aberrant DNA hypermethylation.
@en
Dysregulation of the epigenome ...... aberrant DNA hypermethylation.
@nl
type
label
Dysregulation of the epigenome ...... aberrant DNA hypermethylation.
@en
Dysregulation of the epigenome ...... aberrant DNA hypermethylation.
@nl
prefLabel
Dysregulation of the epigenome ...... aberrant DNA hypermethylation.
@en
Dysregulation of the epigenome ...... aberrant DNA hypermethylation.
@nl
P2093
P1476
Dysregulation of the epigenome ...... aberrant DNA hypermethylation.
@en
P2093
Ashley G Rivenbark
Chad A Livasy
J Devon Roll
Joel S Parker
Lisa A Carey
Rupninder Sandhu
William B Coleman
P304
P356
10.1016/J.YEXMP.2013.09.001
P577
2013-09-14T00:00:00Z